August 9, 2026 Ambassador Jamieson GreerUnited States Trade Representative600 17th Street NWWashington, DC 20508Re: Section 301 Investigation of Germany’s Pharmaceutical Pricing Policies — DocketID USTR-2026-0463Dear Ambassador Greer,I write today to voice my support of the United States Trade Representative’s decision toinitiate a Section 301 investigation into Germany’s pharmaceutical pricing policies.

 June 15, 2026  Dear Members of the Senate Committee on Health, Education, Labor and Pensions:  The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition uniting the biopharmaceutical industry and America’s building trades unions around a shared commitment to medical innovation and high-quality union jobs, strongly opposes the Medication Affordability and Patent

May 20, 2026 The Pharmaceutical Industry Labor-Management Association (PILMA) issued the following statement in response to the potential inclusion of a Most Favored Nation drug pricing proposal ahead of an anticipated vote on the Senate’s budget reconciliation bill. While we believe it is crucial that policymakers prioritize making healthcare more

April 16, 2026 The Honorable Bill Cassidy, M.D. Chairman Committee on Health, Education, Labor, and Pensions United States Senate 428 Dirksen Senate Office Building Washington, DC 20510 The Honorable Bernie Sanders Ranking Member Committee on Health, Education, Labor, and Pensions United States Senate 428 Dirksen Senate Office Building Washington, DC